German Proteomics Co. Gets off the Ground with $16M in Seed Financing | GenomeWeb

NEW YORK, Nov 20 – Meltec, a new German proteomics company whose robotic system allows researchers to perform high-resolution analysis of the location of cell proteins, announced Monday that it has completed its initial round of seed financing with 38 million German marks ($16 million).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.